A study in the January 2010 <i>Gastroenterology</i> assesses long-term clinical outcomes of Hepatocellular carcinoma patients treated with intra-arterial yttrium-90 microspheres. Dr. Kuemmerle speaks to senior author Dr. Riad Salem from the Division of Hematology and Oncology, Northwestern Memorial Hospital, Chicago, Illinois.